Opzelura

Indicated For

mild to moderate atopic dermatitis, nonsegmental vitiligo

About This Medication

# IncyteCARES for OPZELURA: A Complete Patient Guide to Getting Ruxolitinib Cream at Low or No Cost ## Who Qualifies for the IncyteCARES for OPZELURA? If you have been prescribed Opzelura (ruxolitinib cream) and cannot afford it, you may qualify to receive it at little or no cost through the **IncyteCARES for OPZELURA** patient assistance program. To start, if you are a single-person household, your annual income must be at or below **$90,360** to be considered. On the insurance side, this program is designed for patients who are uninsured, underinsured, or enrolled in government-funded insurance such as Medicare or Medicaid — as long as your current coverage does not adequately pay for Opzelura. Meeting both the income and insurance criteria is generally required, but each application is reviewed individually by Incyte. --- ## About Opzelura (ruxolitinib cream) Opzelura is a prescription topical cream that contains ruxolitinib, a Janus kinase (JAK) inhibitor. It is FDA-approved to treat two conditions: **mild to moderate atopic dermatitis** in adults and children 12 years and older, and **nonsegmental vitiligo** in adults and adolescents 12 years and older. As a newer class of topical medication, Opzelura carries a higher price tag than many older creams or ointments. Without insurance or financial assistance, the out-of-pocket cost can reach several hundred dollars or more per tube per month, making it out of reach for many patients who need it. --- ## Income Eligibility: Full Breakdown IncyteCARES for OPZELURA uses an income threshold set at approximately **600% of the Federal Poverty Level (FPL)**. The table below shows the maximum annual household income allowed based on household size for 2025: | Household Size | Max Annual Income | |---|---| | 1 person | $90,360 | | 2 persons | $122,640 | | 3 persons | $154,920 | | 4 persons | $187,200 | For households larger than four people, the income limit typically increases in a similar pattern — contact IncyteCARES directly at **(855) 463-3463** to ask about your specific situation. To verify your income, the program will generally ask for your most recent federal tax return, a W-2 form, or three months of recent pay stubs. If your income changed significantly since last year, recent pay stubs may better reflect your current situation. If your income is above the limit shown for your household size, you may not qualify for free medication through this program. However, you may still have other options — see the "Alternatives If You Don't Qualify" section below for next steps. --- ## Insurance Requirements Explained Your insurance status plays a key role in whether you are eligible. Here is how different situations are handled: - **If you are uninsured:** You likely meet the insurance requirement for the program, as long as you also meet the income criteria. Uninsured patients are one of the primary groups this program is designed to help. - **If you have Medicare Part D:** You may still qualify. Unlike some assistance programs that automatically exclude Medicare beneficiaries, IncyteCARES accepts patients with government-funded insurance — including Medicare — if you meet the financial criteria and your Medicare plan does not adequately cover Opzelura. - **If you have private insurance that covers Opzelura poorly or incompletely:** You may be considered underinsured. If your plan leaves you with costs you cannot reasonably afford, you may qualify. Your application will be reviewed on a case-by-case basis. - **If you have Medicaid:** You may qualify if Medicaid does not cover Opzelura or places it in a tier that results in inadequate coverage. Eligibility is assessed individually and is not automatically denied based on Medicaid enrollment alone. --- ## Step-by-Step: How to Apply Follow these steps to apply for the IncyteCARES for OPZELURA program: 1. **Gather your documents before you start.** You will need: a completed IncyteCARES Patient Enrollment Form, proof of household income (tax return, W-2, or recent pay stubs), signatures from both you and your prescriber, and a current prescription for Opzelura. 2. **Download or request the enrollment form.** Visit the program's official support page at [https://www.opzelura.com/support](https://www.opzelura.com/support) to find the form, or call **(855) 463-3463** to have one sent to you. 3. **Complete the form carefully.** Fill in all required fields. Incomplete forms are a common reason for delays. Make sure your prescriber signs their section before you submit. 4. **Choose your submission method:** - **Online (fastest):** Submit your application at [https://www.incytecares.com/opzelura/patient](https://www.incytecares.com/opzelura/patient) - **By phone:** Call **(855) 463-3463** for assistance - **By fax:** Send completed documents to **(855) 552-3341** 5. **Submit your income documentation** along with your completed enrollment form, whichever method you choose. 6. **Wait for a decision.** IncyteCARES typically completes an initial review within **2 business days** of receiving a complete application. 7. **Watch for a confirmation call or letter** from IncyteCARES confirming your approval and next steps. --- ## What to Expect: Timeline and Delivery Once you submit a complete application, IncyteCARES typically conducts its review within **2 business days**. If approved, you will be notified — usually by phone or mail — with details about your coverage. Opzelura is **shipped directly to your home address**, so you do not need to pick it up at a pharmacy or your doctor's office. There is nothing you need to do at delivery other than receive the package. Your approval is not permanent: **reauthorization is required once per year**. Before your approval period ends, IncyteCARES will typically notify you that it is time to renew. Be ready to provide updated income documentation at that time. --- ## Alternatives If You Don't Qualify If you do not qualify for IncyteCARES, you still have options worth exploring: 1. **Biosimilars:** There are currently **no FDA-approved biosimilar or generic versions** of Opzelura (ruxolitinib cream) available. This option is not yet available but may become one in the future. 2. **Manufacturer savings card (for insured patients):** If you have commercial insurance, Incyte offers a savings card program that may reduce your out-of-pocket costs significantly. You can learn more and enroll at [https://www.opzelura.com/savings-support](https://www.opzelura.com/savings-support). Note that this card is typically not available to patients on Medicare or Medicaid. 3. **State Pharmaceutical Assistance Programs (SPAPs):** Many states run their own prescription assistance programs, especially for older adults or people with disabilities. Search your state's health department website or ask your doctor's office for a referral. 4. **NeedyMeds.org:** This free, nonprofit database at [https://www.needymeds.org](https://www.needymeds.org) lists hundreds of assistance programs by drug name, condition, and state. It is a helpful starting point if IncyteCARES is not the right fit for your situation. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Incyte. Program terms may change — verify current requirements at [https://www.opzelura.com/support](https://www.opzelura.com/support) before applying.* ---

Program information last verified: February 27, 2026